The Traderszone Network

Published in TZ Latest News 13 April, 2017 by The TZ Newswire Staff

Here’s Why the Best Is Yet to Come for Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals (NASDAQ: IONS) has had plenty of good news over the last couple of months:

But the best is yet to come for the biotech.

Image source: Getty Images.

Continue reading